Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Novartis Ag ADR (NVS)

Novartis Ag ADR (NVS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 211,452,976
  • Shares Outstanding, K 2,288,700
  • Annual Sales, $ 49,898 M
  • Annual Income, $ 8,072 M
  • 60-Month Beta 0.54
  • Price/Sales 4.38
  • Price/Cash Flow 11.05
  • Price/Book 4.25
Trade NVS with:

Options Overview

Details
  • Implied Volatility 14.66%
  • Historical Volatility 14.48%
  • IV Percentile 6%
  • IV Rank 1.56%
  • IV High 66.00% on 12/16/20
  • IV Low 13.85% on 06/21/21
  • Put/Call Vol Ratio 0.54
  • Today's Volume 893
  • Volume Avg (30-Day) 996
  • Put/Call OI Ratio 0.34
  • Today's Open Interest 58,475
  • Open Int (30-Day) 56,719

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate 1.50
  • Number of Estimates 3
  • High Estimate 1.55
  • Low Estimate 1.46
  • Prior Year 1.35
  • Growth Rate Est. (year over year) +11.11%

Price Performance

See More
Period Period Low Period High Performance
1-Month
87.92 +5.16%
on 05/28/21
94.77 -2.44%
on 06/16/21
+4.44 (+5.04%)
since 05/24/21
3-Month
85.17 +8.56%
on 04/30/21
94.77 -2.44%
on 06/16/21
+6.44 (+7.49%)
since 03/24/21
52-Week
77.04 +20.02%
on 10/30/20
98.52 -6.15%
on 01/25/21
+3.66 (+4.12%)
since 06/24/20

Most Recent Stories

More News
Roche's (RHHBY) BLA for PDS With Ranibizumab Accepted by FDA

The FDA accepts and grants Priority Review to Roche's (RHHBY) application for Port Delivery System with ranibizumab for the treatment of nAMD.

REGN : 544.45 (+2.77%)
NVS : 92.46 (+0.08%)
RHHBY : 46.6000 (+1.02%)
RGEN : 192.87 (-0.03%)
Global Cataract Surgery Devices Market Size, Analysis Revenue Share to Increase At 4.4% CAGR Through 2025

Selbyville, Delaware, The Cataract Surgery Devices market study now available with Market Study Report, LLC, is a collation of valuable insights related to market size, market share, profitability margin,...

AGN : 193.02 (+0.02%)
CZMWF : 188.2500 (+0.40%)
GKOS : 86.25 (-0.14%)
NVS : 92.46 (+0.08%)
STAA : 154.96 (+1.39%)
TOPCF : 14.9140 (-2.67%)
VRX.TO : 30.80 (-3.33%)
Bacterial Conjunctivitis Drugs Market Provides an In-Depth Insight of Sales, Revenue, Analysis of Growth Factors and Upcoming Trends, Opportunities by Types and Application to 2030

In a recent published report, Kenneth Research has updated the market report for Bacterial Conjunctivitis Drugs Market for 2021 till 2030. Report further now discusses; the various strategies to be adopted...

BAYRY : 15.3500 (+1.05%)
MRK : 76.36 (+1.03%)
NVS : 92.46 (+0.08%)
SHPG : 179.20 (+4.10%)
VRX.TO : 30.80 (-3.33%)
Pain Relief Therapeutics Market 2021 Opportunity Assessment, Business Opportunities, Top Industry Players, Trend and Growth to 2027

ABT : 111.70 (+0.78%)
ACRX : 1.3700 (+1.48%)
ACOR : 5.01 (+2.24%)
AXSM : 70.51 (+1.19%)
BAYRY : 15.3500 (+1.05%)
BDRFF : 119.0500 (+0.89%)
BDSI : 3.70 (+3.35%)
BMY : 65.85 (+0.90%)
COLL : 24.15 (+2.07%)
DEPO : 7.30 (+1.67%)
DRRX : 1.7000 (+1.19%)
EGLT : 0.0315 (-63.37%)
LLY : 232.97 (+7.31%)
FLXN : 9.22 (+3.25%)
GLPG : 68.86 (-0.52%)
HRTX : 15.79 (-3.84%)
KMPH : 14.25 (-0.35%)
MRK : 76.36 (+1.03%)
MESO : 8.45 (+0.72%)
NKTR : 17.02 (+2.10%)
NVS : 92.46 (+0.08%)
ORXOY : 4.5250 (-7.84%)
PFE : 39.19 (+0.36%)
REGN : 544.45 (+2.77%)
VRX.TO : 30.80 (-3.33%)
Novartis and Hewlett Packard Enterprise Join Forces to Advance Novartis Global Health Efforts

--News Direct--

NVS : 92.46 (+0.08%)
Parkinson’s Dyskinesia Market Research Report with Size, Share, Value, CAGR, Outlook, Analysis, Latest Updates, Data, and News 2020-2025

Parkinson's disease is a long term neurodegenerative disorder which affects the dopamine producing neurons in specific areas of the brain known as substantia nigra. This disease belongs to a group of conditions...

ACAD : 25.01 (+2.00%)
GSK : 39.70 (-0.38%)
IPXL : 18.30 (unch)
MRK : 76.36 (+1.03%)
NWPHF : 2.8000 (+0.36%)
NVS : 92.46 (+0.08%)
TEVA : 10.42 (+2.16%)
VRX.TO : 30.80 (-3.33%)
Psoriasis Drug Market Forecast by Region, Forecast by Demand, Environment Forecast, Impact of COVID-19, Geopolitics Overview, Economic Overview of Major Countries 2021-2027

The Psoriasis Drug market report provides a detailed analysis of the emerging trends, opportunities, and as well as the challenges in the market. This extensive report sheds light on the latest developments,...

AMGN : 240.95 (+0.94%)
BIIB : 349.16 (-6.11%)
CELGZ : 0.47 (+2.15%)
LLY : 232.97 (+7.31%)
GSK : 39.70 (-0.38%)
MRK : 76.36 (+1.03%)
NVS : 92.46 (+0.08%)
PFE : 39.19 (+0.36%)
TKPYY : 16.5900 (-0.90%)
VRX.TO : 30.80 (-3.33%)
Valeo Pharma Announces Commercial Launch of Enerzairœ Breezhalerœ and Atecturaœ Breezhalerœ

"The commercial launch of Enerzair Breezhaler and Atectura Breezhaler is a key milestone for Valeo. It marks the debut of the Company's commercial efforts in the Canadian asthma market, one of largest...

NVS : 92.46 (+0.08%)
VPH.CN : 0.890 (-2.20%)
VPHIF : 0.7429 (+3.41%)
Anti-Hypertensive Drugs Global Market Report 2021: COVID-19 Impact And Recovery To 2030

Reportlinker.com announces the release of the report "Anti-Hypertensive Drugs Global Market Report 2021: COVID-19 Impact And Recovery To 2030" - https://www.reportlinker.com/p06097019/?utm_source=GNW

BAYRY : 15.3500 (+1.05%)
DSNKY : 22.2150 (-0.43%)
MRK : 76.36 (+1.03%)
NVS : 92.46 (+0.08%)
PFE : 39.19 (+0.36%)
Kidney Cancer Drugs Global Market Report 2021: COVID-19 Impact And Recovery To 2030

Reportlinker.com announces the release of the report "Kidney Cancer Drugs Global Market Report 2021: COVID-19 Impact And Recovery To 2030" - https://www.reportlinker.com/p06097027/?utm_source=GNW

BAYRY : 15.3500 (+1.05%)
EXEL : 22.86 (+2.88%)
NVS : 92.46 (+0.08%)
PFE : 39.19 (+0.36%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Novartis AG is committed to improving health and well-being through innovative products and services. The company aspires to capture and hold a leadership position in all of their businesses with a strong, sustainable performance based on continuous innovation. Their long-term success is founded on...

See More

Key Turning Points

3rd Resistance Point 93.68
2nd Resistance Point 93.43
1st Resistance Point 92.94
Last Price 92.46
1st Support Level 92.20
2nd Support Level 91.95
3rd Support Level 91.46

See More

52-Week High 98.52
Last Price 92.46
Fibonacci 61.8% 90.31
Fibonacci 50% 87.78
Fibonacci 38.2% 85.25
52-Week Low 77.04

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar